DAOgest and Dermial are targeted for digestive health and skin & beauty respectively
Global life science company Bioiberica has announced two additions to its branded ingredients portfolio at Vitafoods 2022. DAOgest and Dermial are targeted for digestive health and skin & beauty respectively. The company is also spotlighting delivery formats for its Collavant n2 native (undenatured) type II collagen ingredient for joint health at the event.
Histamine intolerance affects an estimated 1-3% of the global population, causing them to experience allergy-like symptoms after consuming histamine rich foods. Until now, Bioiberica says, market opportunities around this condition have remained largely unmet. DAOgest, a digestive health supplement ingredient, which provides diamine oxidase (DAO) enzyme to improve histamine digestion. The extract can reportedly provide an immediate effect at a low dose of 4.2 mg/serving.
Jaume Reguant, Healthcare Director at Bioiberica said: “We’re calling on our industry partners to join forces with us in our goal to develop long-term health solutions that will improve lives for generations to come. With DAOgest, we’re giving manufacturers the opportunity to do just that – to create finished dosage forms that have the power to enable those suffering with this digestive condition to enjoy their favourite foods and drinks.”
The nutricosmetics market is witnessing exponential growth, with today’s health-conscious consumers seeking products to support beauty-from-within. For formulators exploring product developments in this space, Bioiberica has introduced Dermial, a hyaluronic acid matrix ingredient designed for inclusion in dietary supplements, functional foods and nutricosmetics. The ingredient is easy to formulate at a low daily dose (60 mg) and exhibits excellent organoleptic properties, the company says.
Dermial contains a combination of three naturally-occurring ingredients – hyaluronic acid, glycosaminoglycans (including dermatan and chondroitin sulfate) and hydrolysed collagen. In scientific studies, the composition has been shown to elicit superior results when compared to microbial fermentation origin hyaluronic acid, Bioiberica says, including increased in vitro production of type I collagen by 48%.
In addition, the company is unveiling additional delivery formats offering for its native (undenatured) type II collagen for joint health – Collavant n2.
“Consumers are increasingly opting for formats beyond pills, capsules and softgels – including gummies and functional products – to help them meet specific health and nutrition goals. Gummy solutions, especially, are becoming a preferred format for many,” added Reguant.
Formulators can use the collagen ingredient to develop gummies, sports powders and ready-to-drink shakes.
1. Galvez-Martin P. et al. The FASEB Journal, 2022;xS:in press